Liu YD - Search Results

1

Gpc-3 is a notable diagnostic, prognostic and a latent targeted therapy marker in hepatocellular carcinoma.

Zou ZQ, Ding YP, Long B, Yuh JG, Xu AL, Lang ZW, Zou SY, Liu YD, Ding K, Li YY. Zou ZQ, et al. Among authors: liu yd. Hepatogastroenterology. 2010 Sep-Oct;57(102-103):1285-90. Hepatogastroenterology. 2010. PMID: 21410073 Review.

2

[The relationship between the quality of liver biopsy tissue and the pathological diagnosis].

Ding YP, Ding K, Zhang CC, Zou ZQ, Long B, Lang ZW, Liu YD, Lü Q, Qiang CQ, Li YY. Ding YP, et al. Among authors: liu yd. Zhonghua Gan Zang Bing Za Zhi. 2010 Nov;18(11):867-8. doi: 10.3760/cma.j.issn.1007-3418.2010.11.021. Zhonghua Gan Zang Bing Za Zhi. 2010. PMID: 21138642 Chinese. No abstract available.

3

Serum programmed cell death protein 5 (PDCD5) levels is upregulated in liver diseases.

Chen Y, Zou Z, Xu A, Liu Y, Pan H, Jin L. Chen Y, et al. J Immunoassay Immunochem. 2013;34(3):294-304. doi: 10.1080/15321819.2012.731461. J Immunoassay Immunochem. 2013. PMID: 23656249

4

Overexpression of osteopontin promotes resistance to cisplatin treatment in HCC.

Ding K, Fan L, Chen S, Wang Y, Yu H, Sun Y, Yu J, Wang L, Liu X, Liu Y. Ding K, et al. Oncol Rep. 2015 Dec;34(6):3297-303. doi: 10.3892/or.2015.4306. Epub 2015 Sep 23. Oncol Rep. 2015. PMID: 26397192

5

Prognostic value of postoperative change in liver stiffness in patients with HBV-related hepatocellular carcinoma.

Liu Y, Wang X, Xiao J, Sun J, Zhang Y. Liu Y, et al. J Int Med Res. 2020 Apr;48(4):300060520908763. doi: 10.1177/0300060520908763. J Int Med Res. 2020. PMID: 32290747 Free PMC article.

6

[Correlation between gut microbiota and liver biochemical indicators in patients with chronic hepatitis B].

Zhao Z, Qin S, Wang L, Li L, Liu Y, Deng L, Zou Z. Zhao Z, et al. Sheng Wu Gong Cheng Xue Bao. 2021 Jan 25;37(1):301-311. doi: 10.13345/j.cjb.200279. Sheng Wu Gong Cheng Xue Bao. 2021. PMID: 33501810 Free article. Chinese.

7

Low serum free triiodothyronineis level predicts worse outcome of patients with severe fever with thrombocytopenia syndrome.

Wang L, Liu Y, Yu H, Ding K, Zou Z. Wang L, et al. BMC Infect Dis. 2022 Apr 20;22(1):391. doi: 10.1186/s12879-022-07367-6. BMC Infect Dis. 2022. PMID: 35443632 Free PMC article.

8

Serum mAST/ALT ratio had high predictive value for adverse outcome of severe fever with thrombocytopenia syndrome with severe condition.

Wang L, Liu Y, Qu R, Zou Z. Wang L, et al. BMC Infect Dis. 2023 Mar 17;23(1):168. doi: 10.1186/s12879-023-08121-2. BMC Infect Dis. 2023. PMID: 36932323 Free PMC article.

9

A nomogram including admission serum glycated albumin/albumin ratio to predict mortality in patients with severe fever with thrombocytopenia syndrome.

Wang L, Xie H, Liu Y, Zou Z. Wang L, et al. BMC Infect Dis. 2024 Aug 23;24(1):858. doi: 10.1186/s12879-024-09752-9. BMC Infect Dis. 2024. PMID: 39179974 Free PMC article.

10

Poor durability of lamivudine effectiveness despite stringent cessation criteria: a prospective clinical study in hepatitis B e antigen-negative chronic hepatitis B patients.

Liu F, Wang L, Li XY, Liu YD, Wang JB, Zhang ZH, Wang YZ. Liu F, et al. Among authors: liu yd. J Gastroenterol Hepatol. 2011 Mar;26(3):456-60. doi: 10.1111/j.1440-1746.2010.06492.x. J Gastroenterol Hepatol. 2011. PMID: 21332542

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

500 results

Search Page

Filters